STEER: 3D Printed Guide for Nerve Regrowth Control and Neural Interface in Non-Human Primate Model

Blasiak, Agata; Ng, Kian Ann; Wong, Dian Sheng; Tsai, Chne-Wuen; Rusly, Astrid; Gammad, Gil Gerald Lasam; Voges, Kai; Libedinsky, Camilo; Yen, Shih-Cheng; Thakor, Nitish V.; Lahiri, Amitabha

doi:10.1109/tbme.2021.3113653

IEEE Trans. Biomed. Eng.

2022

DOI: 10.1109/tbme.2021.3113653

|View full text |Cite

STEER: 3D Printed Guide for Nerve Regrowth Control and Neural Interface in Non-Human Primate Model

Agata Blasiak¹,

Kian Ann Ng

Dian Sheng Wong

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Systems Medicine as a Strategy to Deal with Alzheimer’s Disease

Zeng,

Zeng

2023

JAD

View full text Add to dashboard Cite

The traits of Alzheimer’s disease (AD) include amyloid plaques made of Aβ1-40 and Aβ1-42, and neurofibrillary tangles by the hyperphosphorylation of tau protein. AD is a complex disorder that is heterogenous in genetical, neuropathological, and clinical contexts. Current available therapeutics are unable to cure AD. Systems medicine is a strategy by viewing the body as a whole system, taking into account each individual’s unique health profile, provide treatment and associated nursing care clinically for the patient, aiming for precision. Since the onset of AD can lead towards cognitive impairment, it is vital to intervene and diagnose early and prevent further progressive loss of neurons. Moreover, as the individual’s brain functions are impaired due to neurodegeneration in AD, it is essential to reconstruct the neurons or brain cells to enable normal brain functions. Although there are different subtypes of AD due to varied pathological lesions, in the majority cases of AD, neurodegeneration and severe brain atrophy develop at the chronic stage. Novel approaches including RNA based gene therapy, stem cell based technology, bioprinting technology, synthetic biology for brain tissue reconstruction are researched in recent decades in the hope to decrease neuroinflammation and restore normal brain function in individuals of AD. Systems medicine include the prevention of disease, diagnosis and treatment by viewing the individual’s body as a whole system, along with systems medicine based nursing as a strategy against AD that should be researched further.

show abstract

Systems Medicine as a Strategy to Deal with Alzheimer’s Disease

Zeng,

Zeng

2023

JAD

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

STEER: 3D Printed Guide for Nerve Regrowth Control and Neural Interface in Non-Human Primate Model

Cited by 1 publication

References 23 publications

Systems Medicine as a Strategy to Deal with Alzheimer’s Disease

Systems Medicine as a Strategy to Deal with Alzheimer’s Disease

Contact Info

Product

Resources

About